| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J9271 |
Injection, pembrolizumab, 1 mg |
374 |
282 |
$3.03M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,236 |
5,150 |
$358K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
3,180 |
1,843 |
$222K |
| J2505 |
Injection, pegfilgrastim, 6 mg |
47 |
36 |
$206K |
| J1453 |
Injection, fosaprepitant, 1 mg |
900 |
566 |
$186K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
1,783 |
1,083 |
$148K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,526 |
2,282 |
$93K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
142 |
138 |
$82K |
| 80053 |
Comprehensive metabolic panel |
5,602 |
4,120 |
$47K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,178 |
1,255 |
$41K |
| 85027 |
|
7,619 |
5,001 |
$40K |
| 99215 |
Prolong outpt/office vis |
398 |
363 |
$32K |
| 99205 |
Prolong outpt/office vis |
274 |
272 |
$31K |
| 96417 |
|
772 |
527 |
$30K |
| 96367 |
|
1,129 |
775 |
$23K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
166 |
166 |
$14K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
329 |
224 |
$12K |
| 96415 |
|
468 |
334 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,138 |
672 |
$11K |
| 96411 |
|
284 |
192 |
$10K |
| 83735 |
|
1,769 |
994 |
$9K |
| 99245 |
|
66 |
66 |
$8K |
| 82728 |
|
669 |
660 |
$7K |
| 96523 |
|
483 |
390 |
$7K |
| J9045 |
Injection, carboplatin, 50 mg |
278 |
190 |
$7K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
69 |
68 |
$6K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
81 |
81 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
319 |
306 |
$4K |
| 83615 |
|
737 |
663 |
$3K |
| 96368 |
|
325 |
217 |
$3K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
109 |
53 |
$3K |
| 84466 |
|
280 |
277 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,130 |
1,200 |
$2K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
191 |
108 |
$2K |
| J9190 |
Injection, fluorouracil, 500 mg |
124 |
67 |
$1K |
| 83540 |
|
292 |
288 |
$1K |
| 90686 |
|
81 |
78 |
$1K |
| 99441 |
|
115 |
113 |
$1K |
| J2060 |
Injection, lorazepam, 2 mg |
1,546 |
929 |
$758.70 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
79 |
77 |
$627.82 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
281 |
173 |
$617.53 |
| 84439 |
|
95 |
92 |
$595.61 |
| 84100 |
|
139 |
123 |
$524.28 |
| 99442 |
|
38 |
35 |
$509.04 |
| 96402 |
|
17 |
12 |
$317.34 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
399 |
206 |
$273.05 |
| 86304 |
|
15 |
12 |
$248.95 |
| J9267 |
Injection, paclitaxel, 1 mg |
26 |
13 |
$238.12 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
250 |
207 |
$214.32 |
| 82378 |
|
15 |
15 |
$175.80 |
| 82607 |
|
14 |
14 |
$112.74 |
| 81001 |
|
21 |
12 |
$61.32 |
| 85045 |
|
14 |
13 |
$46.20 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
17 |
12 |
$19.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
15 |
12 |
$17.17 |
| S0028 |
Injection, famotidine, 20 mg |
24 |
12 |
$12.00 |